Atypical lipomatous tumor (ALT) and welldifferentiated liposarcoma (WDL) are rare liposarcoma subtypes that are histologically identical but distinguished by the 2002 WHO classification: ALTs occur in surgically amenable locations, whereas WDLs do not. This distinction exists because these tumors do not tend to recur after complete surgical removal, despite their infiltrative growth pattern and locally aggressive behavior.
1
A 60-year-old male nonsmoker presented for evaluation of several months of throat irritation and a sense of something stuck in his throat. Physical examination was normal, except flexible endoscopy revealed a benignappearing, pedunculated mass with normal-appearing mucosa extending from the posterolateral pharyngeal wall onto the arytenoid tower. Computed tomography showed a benign-appearing mass within the left hypopharynx effacing the pyriform sinus.
The patient underwent transoral robotic surgical (TORS) excision of the mass. It was 5 cm in size, pedunculated and bilobed ( figure 1, A) . It was excised, leaving an approximately 1-cm mucosal defect. The specimen was soft and pink ( figure 1, B) . Microscopic examination revealed a relatively circumscribed, adipocytic proliferation arranged in lobules of mature-appearing adipose tissue with prominent intervening fibrous septae. Random distribution of enlarged hyperchromatic cells with mild nuclear atypia and occasional multinucleation involved both the adipose and stromal components. Scarce lipoblasts and a rare hibernoma-like nodule were appreciated. Neither necrosis nor mitotic activity was identified. Cells were immunoreactive for MDM2 and p16, and nonreactive for p53, consistent with ALT (figure 2). Three months postoperatively, the patient had no evidence of recurrence.
ALT rarely presents in the laryngopharynx. Three of these were in the upper aerodigestive tract. In 1999, Mandell et al compiled reports of eight hypopharyngeal liposarcomas from three studies, all of which were ALT/WDLs; they had a strong male predominance (7/8) and a size ranging from 2 to 14.5 cm. in the hypopharynx and three in the larynx, ranging from 2.0 to 5.0 cm. 2 Dysphagia, dysphonia, and globus sensation were typical presenting symptoms.
Immunohistochemistry staining of MDM-2, a negative regulator of the p53 tumor suppressor, and p16 have emerged as markers for ALT/WDL. A 2017 study of 101 ALTs showed that dual p16 and MDM2 testing yielded a 100% positive predictive value and a 100% negative predictive value when MDM2+/p16+ and MDM2-/p16-staining were observed for ALT-WDL, respectively. 5 Surgical excision in the hypopharynx can be challenging because of inadequate access and visualization. Classic approaches include lateral pharyngotomy or direct suspension microlaryngoscopy. 6 Radiation is not recommended as primary therapy for hypopharyngeal ALTs but has been offered as adjunctive therapy. 3, 4 If TORS continues to show a low recurrence rate for ALTs, it will further differentiate them from WDLs.
